Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject
Clinical trial NCT06389942 · COMPLETED
Trial details
- NCT number
- NCT06389942
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2024-05-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.